Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2928 (abbreviated as LINC02928) is a human long intergenic non-coding RNA gene. LincRNAs are a type of long non-coding RNA transcribed from genomic regions that do not overlap protein-coding genes. LincRNAs in general may participate in various regulatory processes, such as modulation of gene expression, chromatin structure modulation, or organizing nuclear domains; however, there is no specific information available about the function, disease association, or druggability of LINC02928[1][3][5]. There are no data supporting its role as a therapeutic target, biomarker, or involvement in any disease pathways. Its annotation is limited to its identification as a lincRNA. No common alternative names/aliases have been reported, and it is not associated with any characterized molecular or disease role in the literature. Summary: - LINC02928 is a genomic locus encoding a long intergenic non-coding RNA. - No functional characterization, disease association, or therapeutic targeting information is currently available. - Its only validated molecular classification is as a lincRNA.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2928 (LINC02928).